Skip to main content

Advertisement

Log in

Inhibitory effects of simvastatin on staphylococcus aureus lipoteichoic acid-induced inflammation in human alveolar macrophages

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

Staphylococcus aureus (S. aureus) is the most common bacterium in sepsis and pneumonia involving gram-positive bacteria. Lipoteichoic acid (LTA) is a cell wall component of gram-positive bacteria. It is a potent inducer of inflammatory mediators in human dendritic cells, human pulmonary epithelial cells, and murine macrophages. However, the effect of LTA on human alveolar macrophages (AMs) which are the major effector cells in host defense against respiratory tract infections has hardly been studied. Statins have anti-inflammatory, immunomodulatory, antioxidative, anticoagulant, and antibacterial activities. These effects may be contributed to reduce the markers of systemic inflammation. Emerging retrospective studies have demonstrated that statin use decreased the mortality of pneumonia. However, the precise mechanisms responsible for these effects are unclear. The purpose of this study is to define the role of S. aureus LTA in human AMs and the effects of simvastatin (SV) on LTA-stimulated human AMs. The results showed that LTA induced tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), IL-8 mRNA expression, and suppressed IL-10 mRNA expression in human AMs. Simultaneously, LTA induced human AMs apoptosis. These effects were parallel with the up-regulation of the expression of NF-κB-P65 protein in the LTA-stimulated human AMs. The above effects of LTA on human AMs were inhibited significantly by SV. These data indicate that S. aureus LTA induces potent pro-inflammatory and pro-apoptotic effects on human AMs and statins exert anti-inflammatory effects by mediating inhibition of NF-κB activation and cytokine mRNA expression in human AMs. These results may explain, in part, the mechanisms responsible for favorable effects of statins on pneumonia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

AMs:

Alveolar macrophages

LTA:

Lipoteichoic acid

S. aureus :

Staphylococcus aureus

SV:

Simvastatin

References

  1. Abe Y, Murano M, Murano N et al (2012) Simvastatin attenuates intestinal fibrosis independent of the anti-inflammatory effect by promoting fibroblast/myofibroblast apoptosis in the regeneration/healing process from TNBS-induced colitis. Dig Dis Sci 57:335–344

    Article  CAS  PubMed  Google Scholar 

  2. Ballantyne CM, Corsini A, Davidson MH et al (2003) Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med 163:553–564

    Article  CAS  PubMed  Google Scholar 

  3. Bosma JW, Siegert CE, Peerbooms PG et al (2010) Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial. Nephrol Dial Transplant 25:1213–1217

    Article  CAS  PubMed  Google Scholar 

  4. Cao L, Qian LL, Zhu YR et al (2003) Regulation of activity of nuclear factor-kappaB and activator protein-1 by nitric oxide, surfactant and glucocorticoids in alveolar macrophages from piglets with acute lung injury. Acta Pharmacol Sin 24:1316–1323

    CAS  PubMed  Google Scholar 

  5. Cox KH, Cox ME, Woo-Rasberry V et al (2012) Pathways involved in the synergistic activation of macrophages by lipoteichoic acid and hemoglobin. PLoS ONE 7:e47333

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Deininger S, Traub S, Aichele D et al (2008) Presentation of lipoteichoic acid potentiates its inflammatory activity. Immunobiology 213:519–529

    Article  CAS  PubMed  Google Scholar 

  7. Eisenhut M (2008) Acute lower respiratory tract infection. N Engl J Med 358:2413-2414; author reply 2414

    Google Scholar 

  8. Fournier B, Philpott DJ (2005) Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev 18:521–540

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Fukui M, Imamura R, Umemura M et al (2003) Pathogen-associated molecular patterns sensitize macrophages to Fas ligand-induced apoptosis and IL-1β release. J Immunol 171:1868–1874

    Article  CAS  PubMed  Google Scholar 

  10. Hayden MS, Ghosh S (2011) NF-kappaB in immunobiology. Cell Res 21:223–244

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Jiang-Shieh YF, Yeh KY, Wei IH et al (2005) Responses of microglia in vitro to the gram-positive bacterial component, lipoteichoic acid. J Neurosci Res 82:515–524

    Article  CAS  PubMed  Google Scholar 

  12. Kellum JA, Kong L, Fink MP et al (2007) Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the genetic and inflammatory markers of sepsis (GenIMS) Study. Arch Intern Med 167:1655–1663

    Article  CAS  PubMed  Google Scholar 

  13. Kim SE, Thanh Thuy TT, Lee JH et al (2009) Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract. Exp Mol Med 41:277–287

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Kiortsis DN, Filippatos TD, Mikhailidis DP et al (2007) Statin-associated adverse effects beyond muscle and liver toxicity. Atherosclerosis 195:7–16

    Article  CAS  PubMed  Google Scholar 

  15. Kulbe H, Hagemann T, Szlosarek PW et al (2005) The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res 65:10355–10362

    Article  CAS  PubMed  Google Scholar 

  16. Lambrecht BN (2006) Alveolar macrophage in the driver’s seat. Immunity 24:366–368

    Article  CAS  PubMed  Google Scholar 

  17. Lazzerini PE, Lorenzini S, Selvi E et al (2007) Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients. Clin Exp Rheumatol 25:696–700

    CAS  PubMed  Google Scholar 

  18. Lee TS, Chang CC, Zhu Y et al (2004) Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110:1296–1302

    Article  CAS  PubMed  Google Scholar 

  19. Li L, Xie X, Luo J et al (2012) Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion. Mol Ther 20:2326–2334

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Li L, Yuan L, Luo J et al (2012) MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med. http://dx.doi.org/10.1007/s10238-012-0186-5

  21. Ma XX, Sun DD, Wang S et al (2011) Nasal carriage of methicillin-resistant Staphylococcus aureus among preclinical medical students: epidemiologic and molecular characteristics of methicillin-resistant S. aureus clones. Diagn Microbiol Infect Dis 70:22–30

    Article  CAS  PubMed  Google Scholar 

  22. Medina RJ, O’neill CL, Devine AB et al (2008) The pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathies. PLoS ONE 3:e2584

    Article  PubMed Central  PubMed  Google Scholar 

  23. Miwa K, Asano M, Horai R et al (1998) Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med 4:1287–1292

    Article  CAS  PubMed  Google Scholar 

  24. Murtola TJ, Syvala H, Pennanen P et al (2011) Comparative effects of high and low-dose simvastatin on prostate epithelial cells: the role of LDL. Eur J Pharmacol 673:96–100

    Article  CAS  PubMed  Google Scholar 

  25. Porter KE, Naik J, Turner NA et al (2002) Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. J Vasc Surg 36:150–157

    Article  PubMed  Google Scholar 

  26. Qazi BS, Tang K, Qazi A (2011) Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis. Int J Inflam 2011:908468

    Article  PubMed Central  PubMed  Google Scholar 

  27. Rajtik T, Carnicka S, Szobi A et al (2012) Pleiotropic effects of simvastatin are associated with mitigation of apoptotic component of cell death upon lethal myocardial reperfusion-induced injury. Physiol Res 61(Suppl 2):S33–41

    CAS  PubMed  Google Scholar 

  28. Sacre SM, Lundberg AM, Andreakos E et al (2007) Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-kappaB activation and cytokine production in primary human cells: TRAM is an adaptor for LPS and LTA signaling. J Immunol 178:2148–2154

    Article  CAS  PubMed  Google Scholar 

  29. Sakoda K, Yamamoto M, Negishi Y et al (2006) Simvastatin decreases IL-6 and IL-8 production in epithelial cells. J Dent Res 85:520–523

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Schmich K, Schlatter R, Corazza N et al (2011) Tumor necrosis factor alpha sensitizes primary murine hepatocytes to Fas/CD95-induced apoptosis in a Bim- and Bid-dependent manner. Hepatology 53:282–292

    Article  CAS  PubMed  Google Scholar 

  31. Seo HS, Michalek SM, Nahm MH (2008) Lipoteichoic acid is important in innate immune responses to gram-positive bacteria. Infect Immun 76:206–213

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Shyamsundar M, Mckeown ST, O’kane CM et al (2009) Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 179:1107–1114

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Tleyjeh IM, Kashour T, Hakim FA et al (2009) Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch Intern Med 169:1658–1667

    Article  PubMed  Google Scholar 

  34. Tschoeke SK, Oberholzer C, Laface D et al (2008) Endogenous IL-10 regulates sepsis-induced thymic apoptosis and improves survival in septic IL-10 null mice. Scand J Immunol 68:565–571

    CAS  PubMed Central  PubMed  Google Scholar 

  35. Tuomisto TT, Lumivuori H, Kansanen E et al (2008) Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2. Cardiovasc Res 78:175–184

    Article  CAS  PubMed  Google Scholar 

  36. Van Hal SJ, Paterson DL (2011) New Gram-positive antibiotics: better than vancomycin? Curr Opin Infect Dis 24:515–520

    Article  PubMed  Google Scholar 

  37. Viasus D, Garcia-Vidal C, Gudiol F et al (2010) Statins for community-acquired pneumonia: current state of the science. Eur J Clin Microbiol Infect Dis 29:143–152

    Article  CAS  PubMed  Google Scholar 

  38. Wu B, Zhang W, Huang J et al (2010) Effect of recombinant Panton-valentine leukocidin in vitro on apoptosis and cytokine production of human alveolar macrophages. Can J Microbiol 56:229–235

    Article  CAS  PubMed  Google Scholar 

  39. Wu BQ, Zhi MJ, Liu H et al (2011) Inhibitory effects of lipoteichoic acid from Staphylococcus aureus on platelet function and platelet-monocyte aggregation. Inflamm Res 60:775–782

    Article  CAS  PubMed  Google Scholar 

  40. Yang B, Hosgood SA, Bagul A et al (2011) Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1beta in isolated hemoperfused kidneys. Eur J Pharmacol 660:420–430

    Article  CAS  PubMed  Google Scholar 

  41. Yang Y, Luo C, Feng R et al (2011) The TNF-alpha, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol 137:947–952

    Article  CAS  PubMed  Google Scholar 

  42. You HJ, Choi CY, Kim JY et al (2001) Ursolic acid enhances nitric oxide and tumor necrosis factor-alpha production via nuclear factor-kappaB activation in the resting macrophages. FEBS Lett 509:156–160

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Prof. Xian Rao, Dr. Feng-Li Zhou, and Dr. Jing Huang were greatly appreciated for assisting in the collection of tissue and BAL samples. Grant support: National Science Foundation of China (No. 81170004).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ben-Quan Wu.

Additional information

Ben-Quan Wu and Jin-Mei Luo contributed equally to the work and they are the co-first authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, BQ., Luo, JM., Wang, YH. et al. Inhibitory effects of simvastatin on staphylococcus aureus lipoteichoic acid-induced inflammation in human alveolar macrophages. Clin Exp Med 14, 151–160 (2014). https://doi.org/10.1007/s10238-013-0231-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-013-0231-z

Keywords

Navigation